Gutierrez-Ramos J C, Palacios R
Basel Institute for Immunology, Switzerland.
Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9171-5. doi: 10.1073/pnas.89.19.9171.
Embryonic stem cells can be induced in vitro, by coculture with the stromal line RP.0.10 and a mixture of interleukins 3, 6, and 7, to differentiate into T (Joro75+) and B (B-220+) lymphocyte progenitors and other (Thy-1+, PgP-1+, c-kit+, Joro75-, B-220-, F4/80-, Mac-1-) hemopoietic precursors. The progeny of in vitro-induced embryonic stem cells can reconstitute the lymphoid compartments of T- and B-lymphocyte-deficient scid mice and generate mature T and B lymphocytes in sublethally irradiated normal mice. Exogenous cytokines can dramatically alter the developmental fate of embryonic stem cells in culture. The in vitro system described here should facilitate the study of molecular events leading to cell-lineage commitment and to the formation of hemopoietic stem cells and their immediate lymphoid progeny.
通过与基质细胞系RP.0.10以及白细胞介素3、6和7的混合物共培养,胚胎干细胞可在体外被诱导分化为T(Joro75+)和B(B-220+)淋巴细胞祖细胞以及其他(Thy-1+、PgP-1+、c-kit+、Joro75-、B-220-、F4/80-、Mac-1-)造血前体细胞。体外诱导的胚胎干细胞的后代能够重建T和B淋巴细胞缺陷的重度联合免疫缺陷(scid)小鼠的淋巴区室,并在亚致死剂量照射的正常小鼠中产生成熟的T和B淋巴细胞。外源性细胞因子可显著改变培养中的胚胎干细胞的发育命运。这里描述的体外系统应有助于研究导致细胞谱系定向以及造血干细胞及其直接淋巴祖细胞形成的分子事件。